[Medical Reimbursement] FY2026 Revision, Interpretation of Doubts (Part 1) Released – PT-OT

This timeThe release of "Interpretation of Doubts (Part 1)"marks a crucial juncture where the abstract policy of the medical reimbursement revision is elevated to "absolute rules" directly impacting on-site revenue. Specifically, the detailed presentation of calculation requirements in the rehabilitation field involving PT, OT, and ST will prompt a re-evaluation of the validity of previously maintained additional fees and facility standards.

In the context of medical M&A and business succession, this interpretation of doubts becomesa variable influencing the accuracy of due diligence. For medical institutions considering divestiture, revenue simulations based on the latest interpretations are essential. Failure to meet standards could lead to a significant reduction in goodwill value. Conversely, establishing a system to meet standards early can dramatically increase market scarcity.

As a takeaway for management and successors, rather than dismissing subtle regulatory changes as "administrative matters," it should be viewed as"an opportunity for re-evaluation of the institution's financial strength."If maintaining facility standards independently becomes difficult due to stricter requirements, consider group affiliation and resource sharing as a strategic decision to maximize business value before the revision's impact is fully reflected in financial statements.